Amy Weinfeld Schulman

Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. She focuses on investing in healthcare companies and early-stage biotech start-ups. She also chairs the Board of Directors for Alnylam Pharmaceuticals (NASDAQ: ALNY) and ByHeart, and represents Polaris as a director for Kallyope, Thirty Madison, QurAlis, and Larkspur. She also practiced as a lawyer.

Early life
Both her parents practiced law and were the first in their families to attend college. Her mother, Ann, graduated at the age of 45 and her father after he had served in the US Coast Guards.

Education
She is a Phi Beta Kappa graduate of Wesleyan University, where she received a joint degree in philosophy and English, and she obtained her J.D. from Yale Law School.

Career
Schulman currently serves as a managing partner at Polaris Partners, which focuses on investing in healthcare companies and early-stage biotech start-ups. She also co-founded the Polaris Innovation Fund, which she has managed since its inception in 2017. She serves as chair of the Board of Directors of Alnylam Pharmaceuticals (NASDAQ: ALNY) and as chair of the Board of Directors of ByHeart. She also represents Polaris as a director on various boards, including Thirty Madison, QurAlis, and Larkspur.

Before joining Polaris in 2014, Amy held various roles at Pfizer, beginning with general counsel and moving to the business side as president of Pfizer Nutrition and president of Pfizer Consumer Healthcare. Initially serving as the general counsel, she later transitioned to the business side, becoming the president of both Pfizer Nutrition and Pfizer Consumer Healthcare. Prior to her tenure at Pfizer, she practiced law as a partner at DLA Piper and began her career in litigation at Cleary Gottlieb Steen & Hamilton in 1991.

Philanthropy
Amy is active in philanthropic circles and also serves on the Boards of Action Against Hunger, Mount Sinai Hospital (where she co-chairs the Innovations Committee), and the California Institute of Technology. She is a member of Singapore’s Health and Biomedical Sciences International Advisory Council and the LifeSci NYC Advisory Council.

Recognition
Amy has received numerous awards, including the Margaret Brent Women Lawyers of Achievement Award, Scientific American’s Worldview 100 List, Fierce Biotech’s Top 15 Women in Biotech, and Fortune Magazine’s 50 Most Powerful Women in Business.

Personal life
Schulman is married to David Nachman, and together, they have three children: Ezra, Gideon, and Rafael. Amy and David reside in Brooklyn, New York.